Clinical Trial

Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2025 (before its estimated July 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators will compare the efficacy of Interleukin-6 (IL-6) as a better indicator than procalcitonin in burn patients with sepsis or septic shock regarding success of treatment and early ICU discharge.
Trial Details
NCT Number NCT06915974
Lead Sponsor Ain Shams University
Conditions Burns, Sepsis, Septic Shock, Death
Enrollment 70 participants
Start Date 2025-01-10
Primary Completion 2025-07-10 (estimated)
Study Completion 2025-07-10 (estimated)
Updated on ClinicalTrials.gov 2025-04-08